The ADINA Act mandates drug labels to disclose major food allergens and gluten-containing grains.
The ADINA Act amends the Federal Food, Drug, and Cosmetic Act to require drug labels to identify ingredients that are major food allergens or derived from gluten-containing grains. This applies to drugs intended for human use, with compliance required by a specified date. The act aims to ensure consumers are informed about potential allergens in their medications.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.